- 201. pepsin inhibitor
- [ ] (UMLS (CSP) C0599098) =Pharmacologic Substance; Biologically Active Substance ;
| - 251. PERC INS PRECEREB STENT
- [ ] (UMLS (ICD9CM) C1456045) Percutaneous insertion of other precerebral (extracranial) artery stent(s);
=Therapeutic or Preventive Procedure |
- 202. pepsinogen
- [proenzyme secreted by chief cells, mucous neck cells, and pyloric gland cells which is converted into pepsin in the presence of gastric acid or pepsin itself. ( CSP )] (UMLS (CSP) C0030913) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=proenzyme;
gastric juice | - 252. PERC TRANSMYO REVASCULAR
- [ ] (UMLS (ICD9CM) C1719415) Percutaneous transmyocardial revascularization =Therapeutic or Preventive Procedure
|
- 203. PEPTIC ULCER NOS
- (UMLS (ICD9CM) C0030924) =Acquired Abnormality
| - 253. Percentage
- (UMLS (HL7) C1549488) =Idea or Concept =Amount type;
◊ (UMLS (HL7) C1561533) Idea or Concept Money or percentage indicator; |
- 204. PEPTIC ULCER NOS-OBSTRUC
- [ ] (UMLS (ICD9CM) C0156040) =Disease or Syndrome
| - 254. Percentile
- [Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total. ( NCI )] (UMLS (NCI) C1264641) =Quantitative Concept
|
- 205. Peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation
- (UMLS (ICD9CM) C0030923) =Acquired Abnormality
| - 255. perception
- [the process of producing an internal, conscious image through stimulating a sensory system; it involves the recognition that stimulation has occurred, and the ability to discriminate various aspects of the stimulus. ( CSP )] (UMLS (CSP) C0030971) =Mental Process ;
=cognition;
=body image;
hearing;
illusion;
motion perception;
perceptual distortion;
perceptual masking;
sensory deprivation;
size perception;
space perception;
time perception;
visual perception;
imagery;
form/pattern perception;
somatesthesia;
sensory discrimination;
sensory signal detection;
sequential perception;
speech recognition;
vibration perception |
- 206. Peptidase Family M12B
- [The Peptidase Family-M12B (Reprolysin Family, Adamalysins) consists of evolutionarily-related zinc metalloproteases of structural and functional similarity based on sequence conservation or residue identity. Some family members may not be active enzymes. ( NCI )] (UMLS (NCI) C1335374) =Amino Acid, Peptide, or Protein; Enzyme
| - 256. perception disorder
- [cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs; includes spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body. ( CSP )] (UMLS (CSP) C0030975) =Mental or Behavioral Dysfunction ;
=cognition disorder;
Neurobehavioral Manifestations =hallucination;
agnosia;
Auditory Perceptual Disorders;
hallucination;
illusion;
Phantom Limb;
|
- 207. peptide
- [chemical bond with the structure -CO-CHR-NH-; in biochemistry, polymers of alpha-aminoacids joined by peptide bonds. ( CSP )] (UMLS (NCI) C0030956) =Amino Acid, Peptide, or Protein =amide;
Amino Acids, Peptides, and Proteins =dipeptide;
glutathione;
glycopeptide;
NCS;
netropsin;
neuropeptide;
oligopeptide;
cyclic peptide;
phosphopeptide;
gene product;
homopeptide;
synthetic peptide;
ACTH;
calcitonin;
CCK;
ACTH releasing factor;
Antidiabetic Hormone;
glycopeptide;
oligopeptide;
cyclic peptide;
PDGF;
Polyglutamic Acid;
polylysine;
SECRETIN;
AY 24910;
Tyrothricin;
copolymer 1;
live yeast cell derivative;
integrelin | - 257. Perception Disturbance
- (UMLS (NCI) C0233746) =Mental or Behavioral Dysfunction
|
- 208. Peptide 946
- [A protein that causes white blood cells to recognize and destroy melanoma cells. ( NCI )] (UMLS (NCI) C0254201) =Amino Acid, Peptide, or Protein
| - 258. perceptual closure
- [The tendency to perceive an incomplete pattern or object as complete or whole. This includes the Gestalt Law of Closure. ( MSH )] (UMLS (CSP) C0030972) =Mental Process ;
|
- 209. Peptide 946 Melanoma Vaccine
- [A melanoma peptide vaccine with potential antineoplastic activity. Peptide 946 melanoma vaccine contains one of the peptide sequences for a melanoma-specific epitope that is recognized by melanoma-specific cytotoxic T- lymphocytes (CTL). The vaccine contains a peptide sequence homologous to the native epitope and is often formulated with an adjuvant such as QS-21 or Montanide ISA-51 to boost its immune stimulation. Vaccination with peptide 946 vaccine may produce antibodies as well as elicit a cytotoxic T- lymphocyte (CTL) response against cells expressing this antigen, resulting in decreased tumor cell growth. ( NCI )] (UMLS (NCI) C0677986) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 259. perceptual distortion
- [lack of correspondence between the way a stimulus is commonly perceived and the way an individual perceives it under given conditions. ( CSP )] (UMLS (CSP) C0030976) =Mental Process ;
=perception;
|
- 210. Peptide 946 Melanoma Vaccine/QS21/Tetanus Peptide Melanoma Vaccine
- (UMLS (NCI) C0677992) =Therapeutic or Preventive Procedure
| - 260. perceptual masking
- [interference of one perceptual stimulus with another causing a decrease or lessening in perceptual effectiveness; frequently associated with visual and auditory perception. ( CSP )] (UMLS (CSP) C0030977) =Mental Process ;
=perception;
|
- 211. Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine
- [A melanoma peptide vaccine complexed with tetanus toxoid with potential antineoplastic activity. Peptide 946 contains a melanoma-specific epitope recognized by melanoma-specific cytotoxic T lymphocytes (CTL). In addition to the peptide 946 sequence, this vaccine contains tetanus toxoid, a protein known to stimulate the induction of CD4+ T lymphocytes, and thereby enhance antigen processing and presentation. Vaccination with the peptide 946-tetanus conjugate melanoma vaccine may produce antibodies as well as elicit a cytotoxic T lymphocyte (CTL) response in tumor cells expressing the 946 epitope, thereby, decreasing tumor cell growth. ( NCI )] (UMLS (NCI) C0677987) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 261. percolan
- [ ] (UMLS (CSP) C0597724) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 212. peptide analog
- [synthetic or natural compounds which resemble naturally occurring peptides in structure and/or function. ( CSP )] (UMLS (CSP) C0597191) =Amino Acid, Peptide, or Protein ;
=analog;
=SARALASIN;
glutathione analog;
| - 262. PERCU ABDOMINAL DRAINAGE
- (UMLS (ICD9CM) C0198497) =Therapeutic or Preventive Procedure
|
- 213. peptide biosynthesis
- [The chemical reactions and pathways resulting in the formation of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. [GOC:jl, http://cancerweb.ncl.ac.uk] ( GO )] (UMLS (CSP) C1327133) =Molecular Function
| - 263. PERCU BX GB/BILE DUCT
- [ ] (UMLS (ICD9CM) C0842627) Percutaneous biopsy of gallbladder or bile ducts =Diagnostic Procedure
|
- 214. peptide chemical synthesis
- [in vitro (outside the body, tissue, or cell) synthesis of peptides or peptide compounds; should NOT be used for the in vivo synthesis of peptides, for this concept use PROTEIN BIOSYNTHESIS or GENETIC TRANSLATION. ( CSP )] (UMLS (CSP) C0599100) =Human-caused Phenomenon or Process =chemical synthesis;
| - 264. PERCU ENDOSC GASTROSTOMY
- [ ] (UMLS (ICD9CM) C0176751) =Therapeutic or Preventive Procedure
|
- 215. Peptide Hormone
- [hormones synthesized from amino acids, whose actions are systemic. ( CSP )] (UMLS (NCI) C0597192) =Amino Acid, Peptide, or Protein; Hormone =Endocrine Gland Secretion;
=angiotensin;
calcitonin;
gastrointestinal hormone;
Hypothalamic Hormone;
Folliculostatin;
ANH (atrial natriuretic hormone);
pancreas hormone;
parathyroid hormone;
[HS700] PITUITARY;
placental hormone;
relaxin;
Activin;
Parathyroid Hormone Like Tumor Factor;
endothelin;
leptin;
adiponectin;
MIS | - 265. PERCU ENDOSC JEJUNOSTOMY
- [ ] (UMLS (ICD9CM) C0176813) =Therapeutic or Preventive Procedure
|
- 216. peptide hormone analog
- [synthetic or natural chemical compounds which resemble naturally occurring peptide hormones in structure and/or function. ( CSP )] (UMLS (CSP) C0597193) =Amino Acid, Peptide, or Protein; Hormone =hormone analog;
=1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane Cyclic Peptide Deriv;
6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig);
| - 266. PERCU GASTROJEJUNOSTOMY
- [ ] (UMLS (ICD9CM) C0994537) Percutaneous [endoscopic] gastrojejunostomy =Therapeutic or Preventive Procedure
|
- 217. peptide hormone biosynthesis
- [anabolic formation of peptide hormone compounds in organisms or living cells. ( CSP )] (UMLS (CSP) C0597194) =Molecular Function ;
=hormone biosynthesis;
peptide hormone metabolism | - 267. PERCU NEPHROSTM W/O FRAG
- (UMLS (ICD9CM) C0030990) =Therapeutic or Preventive Procedure ;
|
- 218. Peptide Hormone Gene
- [Peptide Hormone Genes encode Peptide Hormones, typically synthesized as larger precursor molecules from which are derived smaller active proteins that function as hormonal signals secreted by one tissue or organ and have physiological effects on other tissues or organs. ( NCI )] (UMLS (NCI) C1335375) =Gene or Genome ;
| - 268. PERCU NEPHROSTMY W FRAG
- [ ] (UMLS (ICD9CM) C0176985) =Therapeutic or Preventive Procedure
|
- 219. peptide hormone metabolism
- [sum of chemical changes that occur within the tissues of an organism consisting of anabolism (biosynthesis) and catabolism of peptide hormones; the buildup and breakdown of peptide hormones for utilization by the organism. ( CSP )] (UMLS (CSP) C0597195) =Molecular Function ;
=hormone metabolism;
=peptide hormone biosynthesis | - 269. PERCUT PROSTATIC ASPIRAT
- [ ] (UMLS (ICD9CM) C0177092) =Therapeutic or Preventive Procedure
|
- 220. peptide library
- [multiplicity of peptide sequences, often attached to polymeric beads. ( CSP )] (UMLS (CSP) C0376436) =Amino Acid, Peptide, or Protein; Indicator, Reagent, or Diagnostic Aid =technology/technique;
| - 270. PERCUT SEMIN VES ASPIRAT
- [ ] (UMLS (ICD9CM) C0194959) =Therapeutic or Preventive Procedure
|
- 221. Peptide Metabolism
- [Peptide Metabolism involves cellular biotransforming chemical modifications of peptides, low molecular weight compounds containing two or more covalently bound amino acids, by enzymatic activity. ( NCI )] (UMLS (NCI) C1158921) =Molecular Function
| - 271. PERCUT TUNICA ASPIRATION
- [ ] (UMLS (ICD9CM) C0177106) =Therapeutic or Preventive Procedure
|
- 222. peptide nucleic acid
- [DNA analogs containing neutral amide backbone linkages composed of aminoethyl glycine units instead of phosphodiester linkage of deoxyribose groups; high stability and a high affinity for complementary DNA or RNA. ( CSP )] (UMLS (CSP) C0600500) =Nucleic Acid, Nucleoside, or Nucleotide =Nucleic Acid;
| - 272. PERCUTAN ASPIRATION GB
- (UMLS (ICD9CM) C0193444) =Therapeutic or Preventive Procedure
|
- 223. peptide structure
- [ ] (UMLS (CSP) C0597196) =Spatial Concept ;
=chemical structure;
| - 273. PERCUTAN BARTHOLIN ASPIR
- [ ] (UMLS (ICD9CM) C0177245) =Therapeutic or Preventive Procedure
|
- 224. peptide T
- [N-(N-(N(2)-(N-(N-(N-(N-D-Alanyl L-seryl)-L-threonyl)-L-threonyl) L-threonyl)-L-asparaginyl)-L-tyrosyl) L-threonine. Octapeptide sharing sequence homology with HIV envelope protein gp120. It is potentially useful as antiviral agent in AIDS therapy. The core pentapeptide sequence, TTNYT, consisting of amino acids 4-8 in peptide T, is the HIV envelope sequence required for attachment to the CD4 receptor. ( MSH )] (UMLS (CSP) C0030953) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 274. PERCUTAN BLADDER ASPIRAT
- [ ] (UMLS (ICD9CM) C0177023) =Therapeutic or Preventive Procedure
|
- 225. Peptide Transport
- [Peptide Transport involves mechanisms that promote the translocation of a peptide from one location to another. ( NCI )] (UMLS (NCI) C1159777) =Cell Function
| - 275. PERCUTAN FACET DENERVAT
- [ ] (UMLS (ICD9CM) C0196526) =Therapeutic or Preventive Procedure
|
- 226. Peptide Vaccine
- [A vaccine based on a synthetic peptide or peptides produced from tissue samples or recombinant sources. Vaccination with peptide vaccines may elicit host immune responses against antigen-expressing cells. ( NCI )] (UMLS (NCI) C0599934) =Pharmacologic Substance; Immunologic Factor
| - 276. PERCUTAN LIVER ASPIRAT
- (UMLS (ICD9CM) C0193384) =Therapeutic or Preventive Procedure
|
- 227. Peptide/MHC Complex
- [Peptide MHC Complexes consist of proteolytically-processed low molecular weight amino acid fragments of antigenic foreign proteins noncovalently bound to self MHC antigens and displayed on the surface of antigen presenting macrophages to helper T cells as an important part of an immune response. ( NCI )] (UMLS (NCI) C1335376) Peptide-Major Histocompatibility Protein Complex;
Peptide-MHC;
pMHC =Amino Acid, Peptide, or Protein; Immunologic Factor | - 277. PERCUTAN RENAL ASPIRAT
- (UMLS (ICD9CM) C0194061) =Therapeutic or Preventive Procedure
|
- 228. peptidoglycan
- [polysaccharide covalently linked to crosslinked peptides to form a matrix found in bacterial cell walls. ( CSP )] (UMLS (CSP) C0030958) =Organic Chemical; Biologically Active Substance ;
=glycopeptide;
bacterial polysaccharide | - 278. PERCUTANEOUS ANGIOSCOPY
- (UMLS (ICD9CM) C0396814) =Diagnostic Procedure
|
- 229. peptidyl dipeptidase
- [ ] (UMLS (CSP) C0597197) =Amino Acid, Peptide, or Protein; Enzyme =exopeptidase;
=angiotensin converting enzyme | - 279. Percutaneous Biopsy of Kidney
- [Removal of tissue from the kidney, for microscopic examination, obtained percutaneously. ( NCI )] (UMLS (NCI) C0372299) =Diagnostic Procedure ;
|
- 230. Pepto-Bismol
- (UMLS (NCI) C0136074) =Organic Chemical; Pharmacologic Substance ;
| - 280. PERCUTANEOUS CHORDOTOMY
- [ ] (UMLS (ICD9CM) C0196243) =Therapeutic or Preventive Procedure
|
- 231. Peptococcaceae
- [A family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains. ( MSH )] (UMLS (CSP) C0030964) =Bacterium
| - 281. PERCUTANEOUS CYSTOSTOMY
- [ ] (UMLS (ICD9CM) C0177025) =Therapeutic or Preventive Procedure
|
- 232. Per
- (UMLS (NCI) C1418464) =Gene or Genome
| - 282. PERCUTANEOUS HYSTEROGRAM
- [ ] (UMLS (ICD9CM) C0203040) =Diagnostic Procedure
|
- 233. PER CARDIOPULMON BYPASS
- [ ] (UMLS (ICD9CM) C0176692) =Therapeutic or Preventive Procedure
| - 283. Percutaneous Liver Biopsy
- (UMLS (NCI) C0558534) =Diagnostic Procedure
|
- 234. Per Day
- (UMLS (NCI) C0439505) =Temporal Concept
| - 284. Percutaneous Needle Biopsy
- (UMLS (NCI) C0558528) =Therapeutic or Preventive Procedure
|
- 235. per definition
- [ :The observation or test occurred as defined in the research protocol, but at a point in time not specified in the study protocol. ( HL7V3.0 )] (UMLS (HL7) C1699702) =Functional Concept =ActReason;
| - 285. Percutaneous Nephrostomy
- (UMLS (HL7) C1548897) =Health Care Activity =Consent Type;
|
- 236. Per Hour
- (UMLS (NCI) C0564385) =Quantitative Concept
| - 286. PERCUTANEOUS PYELOGRAM
- [ ] (UMLS (ICD9CM) C0177746) =Diagnostic Procedure
|
- 237. Per Minute
- (UMLS (NCI) C0702093) =Temporal Concept ;
| - 287. Percutaneous Transhepatic Cholangiogram
- (UMLS (HL7) C1548898) =Intellectual Product =Consent Type;
|
- 238. per protocol
- [ Definition:The observation or test occurred due to it being defined in the research protocol, and during an activity or event that was scheduled in the protocol. ( HL7V3.0 )] (UMLS (HL7) C1698058) =Functional Concept ;
=ActReason;
| - 288. Percutaneous Transhepatic Cholangiography
- [(per-kyoo-TAN-ee-us trans-heh-PAT-ik ko-LAN-jee-AH-gra-fee). A procedure to x-ray the hepatic and common bile ducts. A contrasting agent is injected into the liver or bile duct, and the ducts are then x-rayed to find the point of obstruction. ( NCI )] (UMLS (NCI) C0203085) =Diagnostic Procedure
|
- 239. Per Second
- (UMLS (NCI) C0565930) =Quantitative Concept
| - 289. Percutaneous Transluminal Coronary Angioplasty
- [A procedure to open an occluded coronary artery, performed by percutaneous introduction of a catheter into a peripheral (usually femoral) artery which is directed in a retrograde fashion to reach the diseased coronary artery. ( NCI )] (UMLS (NCI) C0002997) =Therapeutic or Preventive Procedure
|
- 240. Perandren M
- (UMLS (NCI) C0136079) =Steroid; Pharmacologic Substance; Hormone
| - 290. Percutaneous transluminal coronary angioplasty [PTCA] or coronary atherectomy
- [ ] (UMLS (ICD9CM) C1561752) PTCA OR CORONARY ATHER;
=Therapeutic or Preventive Procedure |
- 241. PERC ABLTN LIVER LES/TIS
- [ ] (UMLS (ICD9CM) C1719479) Percutaneous ablation of liver lesion or tissue =Therapeutic or Preventive Procedure
| - 291. Percutaneous transluminal coronary angioplasty, postsurgical status
- [ ] (UMLS (ICD9CM) C0375852) =Finding
|
- 242. PERC ABLTN LUNG LES/TISS
- [ ] (UMLS (ICD9CM) C1719343) Percutaneous ablation of lung lesion or tissue =Therapeutic or Preventive Procedure
| - 292. Perflubron
- [A synthetic radiopaque liquid form of perfluorooctyl bromide. Used as a contrast agent for magnetic resonance imaging (MRI), perflubron is also used as a liquid ventilation agent to improve pulmonary gas exchange and lung compliance and may be used in surgery to reduce or eliminate the need for donor blood. Ventilation with perfluorocarbon fluid improves lung function in conditions involving surfactant deficiency and dysfunction, including respiratory distress syndrome and adult respiratory distress syndrome. (NCI04) ( NCI )] (UMLS (NCI) C0162922) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Fluorocarbons;
[DX900] DIAGNOSTICS, OTHER;
Unclassified Ingredient Preparations;
=Perflubron Liquid |
- 243. PERC ABLTN RENL LES/TISS
- [ ] (UMLS (ICD9CM) C1719534) Percutaneous ablation of renal lesion or tissue;
=Therapeutic or Preventive Procedure | - 293. perfluorochemical emulsion
- [ ] (UMLS (CSP) C0598452) =Organic Chemical; Pharmacologic Substance ;
|
- 244. PERC ANGIO INTRACRAN VES
- [ ] (UMLS (ICD9CM) C1456042) Percutaneous angioplasty or atherectomy of intracranial vessel(s);
=Therapeutic or Preventive Procedure | - 294. PERFOR ROOT CANAL SPACE
- [ ] (UMLS (ICD9CM) C1719521) Perforation of root canal space;
=Pathologic Function |
- 245. PERC ANGIO PRECEREB VESS
- [ ] (UMLS (ICD9CM) C1456038) Percutaneous angioplasty or atherectomy of precerebral (extracranial) vessel(s);
=Therapeutic or Preventive Procedure | - 295. perforant pathway
- [A pathway of fibers originating in the lateral part of the entorhinal area, perforating the subiculum of the hippocampus, and running into the stratum moleculare of the hippocampus, where these fibers synapse with others that go to the dentate gyrus. It is also called the perforating fasciculus. (MeSH) ( NCI )] (UMLS (CSP) C0524810) =Body Part, Organ, or Organ Component ;
|
- 246. PERC EXTRAC COM DUC CALC
- (UMLS (ICD9CM) C0193470) =Therapeutic or Preventive Procedure
| - 296. Perforated
- [A hole or opening made through a membrane or other tissue or material. ( NCI )] (UMLS (NCI) C0549099) =Finding
|
- 247. PERC HEART VALVULOPLASTY
- [ ] (UMLS (ICD9CM) C0190176) =Therapeutic or Preventive Procedure
| - 297. Perforated corneal ulcer
- (UMLS (ICD9CM) C0151844) =Disease or Syndrome
|
- 248. PERC HEPAT CHOLANGIOGRAM
- [ ] (UMLS (ICD9CM) C0177739) =Diagnostic Procedure
| - 298. PERFORATION GALLBLADDER
- [ ] (UMLS (ICD9CM) C0156215) =Injury or Poisoning
|
- 249. PERC INS CAROTID STENT
- [ ] (UMLS (ICD9CM) C1456043) Percutaneous insertion of carotid artery stent(s);
=Therapeutic or Preventive Procedure | - 299. PERFORATION OF BILE DUCT
- [ ] (UMLS (ICD9CM) C0156218) =Disease or Syndrome
|
- 250. PERC INS INTRACRAN STENT
- [ ] (UMLS (ICD9CM) C1456048) Percutaneous insertion of intracranial vascular stent(s);
=Therapeutic or Preventive Procedure | - 300. Perforation of sinus
- (UMLS (NCI) C0854572) Sinus Perforation;
Sinus, Perforation Of;
=Injury or Poisoning ;
|
home
